BC Clinical Trial Points to Safer ICU Care for Critical Patients
Royal Columbian Hospital and Simon Fraser research published in JAMA shows significant reduction in central-line infections across Canadian intensive care units.
A BC-led clinical research team has published findings in the Journal of the American Medical Association (JAMA) that could reshape how hospitals manage critically ill patients worldwide. Researchers from Royal Columbian Hospital and Simon Fraser University documented a measurable reduction in central-line complications—infections and blockages that kill thousands of ICU patients annually.
Central lines are lifelines in intensive care: catheters inserted into major veins to deliver medications, fluids, and nutrition to patients too sick to eat or drink normally. They're essential, but they carry infection risk. The Canadian ICU study tested a systematic intervention protocol and found it worked. For Montréal hospitals and Quebec's network of critical care units, the research validates practices that can save lives and reduce the length of stay for the sickest patients.
The findings are already being adopted across Canada's ICU system. When a study this significant comes from Canada and gets published in one of the world's most rigorous medical journals, it signals that Canadian clinical research matters on the global stage. For patients in Montreal needing intensive care, it means the hospitals treating them have access to evidence-based protocols that work.